Impact of hepatitis delta virus infection on waiting list outcomes: A competing-risks analysis

Table 1 Baseline characteristics of the delta and hepatitis B virus monoinfection groups, n (%)/median (interquartile range)

Characteristic	Delta (n = 174)	HBV monoinfection (n = 30)	SMD	P value
Age (years)	48.0 (42.0-54.0)	52.0 (47.0-57.8)	0.42	0.037
Female sex	78 (45)	6 (20)	0.55	0.019
Rural residence	107 (61)	14 (47)	0.30	0.185
BMI (kg/m2)	24.8 (22.8-27.1)	27.1 (24.7-30.4)	0.54	0.004
ALT (U/L)	58.1 (39.3-93.1)	43.3 (26.9-64.2)	0.27	0.009
AST (U/L)	76.8 (55.5-116.6)	61.1 (44.2-90.5)	0.27	0.067
Platelets (× 109/L)	72.0 (49.0-103.5)	98.0 (68.5-161.3)	0.44	0.005
Albumin (g/L)	28.0 (24.9-31.9)	29.4 (24.0-35.6)	0.07	0.643
Total bilirubin (μmol/L)	40.6 (23.5-60.5)	45.0 (21.8-79.1)	0.23	0.477
INR	1.5 (1.3-1.7)	1.4 (1.2-1.7)	0.14	0.252
Creatinine (μmol/L)	66.8 (57.7-75.0)	71.2 (57.1-79.2)	0.21	0.327
Sodium (mmol/L)	138.0 (135.0-140.1)	139.0 (136.0-140.8)	0.09	0.466
Ascites	110 (63)	15 (50)	0.27	0.242
Hepatic encephalopathy	68 (39)	10 (33)	0.12	0.676
Esophageal variceal hemorrhage	35 (20)	5 (17)	0.09	0.660
Hepatocellular carcinoma	31 (18)	8 (27)	0.21	0.375
MELD	15.0 (12.0-17.0)	15.5 (11.0-17.0)	0.01	0.992
MELD-Na	15.0 (12.0-18.8)	15.5 (11.0-18.0)	0.07	0.510
MELD 3.0	16.5 (13.0-20.0)	16.5 (12.0-19.0)	0.10	0.652
Waiting-list time (days)	247.5 (102.5-631)	281 (135.2-762.2)	0.13	0.593
Waiting-list death	78 (44.8)	19 (63.3)	0.38	0.094
Transplantation	72 (41.4)	6 (20.0)	0.48	0.043
Delisted	1 (0.6)	0 (0.0)	0.11	1.000
Active in waiting list	23 (13.2)	5 (16.7)	0.10	0.826

HBV: Hepatitis B virus; SMD: Standardized mean difference; BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; INR: International normalized ratio; MELD-Na: Model for end-stage liver disease-sodium; MELD: Model for end-stage liver disease.